Quinta-Analytica's facilities in our HQ in Prague and also at our newest lab in Brno passes the latest GMP inspection by the Czech State Institute for Drug Control, SUKL.
. . .
We’re excited to announce that in recognition of our continued dedication to exceptional quality pharma services, we have just passed our latest GMP inspection by the Czech State Institute for Drug Control, SUKL.
Inspecting QUINTA-ANALYTICA’s facilities in our HQ in Prague and also at our newest lab in the southern Czech city of Brno, the pass in both locations this week once again confirms our position as a fully certified service provider to the global pharmaceutical industry. Something we’ve been doing for over twenty years.
Providing services that span the whole pharmaceutical spectrum and combining them with unrivaled expertise across analytical services, clinical studies, R&D and more, passing both inspections eulogizes another year of growth and success for Quinta and, most importantly, our partners and clients!
18 July 2023
Challenges of a large-scale study of breast cancer
Our bioanalytical experts and a high-profile client team up for the development of a new therapy for breast cancer.
29 June 2023
EU funding for Quinta-Analytica laboratory in Brno (CZ) was succesfully completed.
After two years, the project to finance new equipment for the Quinta-Analytica laboratory in Brno was successfully completed. The investment from European Regional Development Fund was used in this project.
22 June 2023
Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies
EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency